Enguita-Germán M, Librero J, Leache L, Gutiérrez-Valencia M, Tamayo I, Jericó C, et al. Role of the AB0 blood group in COVID-19 infection and complications: A population-based study. Transfus Apher Sci 2022:103357. doi: 10.1016/j.transci.2022.103357.

Leache L, Gutiérrez-Valencia M, Enguita-Germán M, Librero J, Gorricho J, Jericó J, et al. COVinfectation and complications according to ABO blood group in the elderly: A population -based  subcohort and meta-analysis. Vox  Sang 2022. doi: 10.1111/vox.13334.

Cedeño-Veloz A, Erviti J, Gutiérrez-Valencia M, Leache L, Saiz LC, Rodríguez-Garcia AM, et al: Efficacy of antiresorptive Treatment  in Osteoporotic Older Adults: A Systematic Review and Meta-Analysis  of Randomized Clinical Trials. J Nutr Health Aging 2022

Gutiérrez-Valencia M , Leache L, Saiz LC. Revisión de la validez de las escalas de valoración del riesgo de caídas en pacientes hospitalizados. Rev Esp Geriatr Gerontol 2022:57(3):186-194. https://doi.org/10.1016/j.regg.2022.03.005

Prugger C, Spelsberg A, Keil U, Erviti J, Doshi P. Evaluating covid-19 vaccine efficacy and safety in the post-authorisation phase. BMJ 2021;375:e067570. doi: 10.1136/bmj-2021-067570

Gutiérrez-Valencia M, Leache L, Librero J, Jericó C, Enguita Germán M, García-Erce JA. ABO blood group and risk of COVID-19 infection and complications: A systematic review and meta-analysis. Transfusion. 2021. doi: 10.1111/trf.16748

Marta Gutiérrez, Leire Leache, Luis Carlos Saiz. Tendencias suicidas asociadas al uso de antidepresivos en niños y adolescentes. BIT Navarra 2021;29(3). http://www.navarra.es/home_es/Temas/Portal+de+la+Salud/Profesionales/Documentacion+y+publicaciones/Publicaciones+tematicas/Medicamento/BIT/Vol+29/Vol+29+N+3.htm

Leache L, Celaya MC, Alzueta N, Echeverría A, Saiz LC, Erviti J, et al. Effect of “triple whammy” combination in hospitalization due to acute kidney injury: a protocol of a nested case-control study. REV. OFIL·ILAPHAR 2021;31(4). https://www.ilaphar.org/effect-of-triple-whammy-combination-in-hospitalization-due-to-acute-kidney-injury-a-protocol-of-a-nested-case-control-study/

Leache L, Gutiérrez-Valencia M, Finizola RM, Infante E, Finizola B, Pardo Pardo J, et al. Pharmacotherapy for hypertension-induced left ventricular hypertrophy. Cochrane Database Syst Rev 2021;10:CD012039. doi: 10.1002/14651858.CD012039.pub3

Goñi O, Leache L, Lacalle E, Acín MT.What´s left and new in the management of migraine? DTB Navarre 2021;29(1):1-23. http://www.navarra.es/home_en/Temas/Portal+de+la+Salud/Profesionales/Documentacion+y+publicaciones/Publicaciones+tematicas/Medicamento/BIT/Vol+29/DTB+29+N+1.htm

Leache L, Arrizibita O, Gutiérrez-Valencia M, Saiz LC, Erviti J, Librero J. Incidence of Attention Deficit Hyperactivity Disorder (ADHD) Diagnoses in Navarre (Spain) from 2003 to 2019. Int. J. Environ. Res. Public Health 2021;18, 9208 https://doi.org/10.3390/ijerph18179208

Salazar J, Pérez-Bracchiglione J, Salas-Gama K, Antequera A, Auladell-Rispau A, Dorantes-Romandía R, Meade AG, Jesús Quintana M, Requeijo C, Rodríguez-Grijalva G, Santero M, Acosta-Dighero R, Solà I, Urrútia G, Bonfill Cosp X; Systemic Treatments for Advanced Digestive Cancer Research. Efficacy of systemic oncological treatments in patients with advanced pancreatic cancer at high risk of dying in the short or medium-term: overview of systematic reviews. Eur J Cancer 2021;154:82-91. doi: 10.1016/j.ejca.2021.05.034   https://www.ejcancer.com/article/S0959-8049(21)00362-2/fulltext

Leache L, Gutiérrez-Valencia M, Saiz LC, Erviti J. Morbi-mortality of lower respiratory tract infections in Spain, 1997-2018. An. Sist. Sanit. Navar. 2021 Dec 27;44(3):385-396. 
https://doi.org/10.23938/ASSN.0962

Goñi O, Leache L, Lacalle E, Acín MT. Qué queda y qué hay de nuevo en le manejo farmacológico de la migraña. Bit Navarra 2029;29(1):1-23.: http://www.navarra.es/home_es/Temas/Portal+de+la+Salud/Profesionales/Documentacion+y+publicaciones/Publicaciones+tematicas/Medicamento/BIT/Vol+29/BIT+29+N+1.htm

Acin MT, Rueda J-R, Saiz LC, Parent Mathias V, Alzueta N, Solà I, Garjón J, Erviti J. Alcohol intake reduction for controlling hypertension. Cochrane Database of Systematic Reviews 2020;9:CD010022. https://doi.org/10.1002/14651858.CD010022.pub2

Saiz LC, Gorricho J, Garjón J, Celaya MC, Erviti J, Leache L. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease. Cochrane Database Syst Rev 2020;9:CD010315. https://doi.org/10.1002/14651858.CD010315.pub4

Leache L, Saiz LC, Gutiérrez-Valencia M, Erviti J. Medicamentos huérfanos, incentivos e incertidumbre sobre su relación beneficio-riesgo (carta) [Orphan drugs, incentives and uncertainty about their risk-benefit balance]. Gac Sanit 2020. https://doi.org/10.1016/j.gaceta.2020.05.012

Leache L, Saiz LC, Gutiérrez-Valencia M, Erviti J. Transparencia, equidad y acceso a los medicamentos: a propósito de la pandemia por COVID-19. [Transparency, equity and access to medicines: talking of the COVID-19 pandemic] Rev. OFILILAPHAR 2020;30(3):185-188. https://www.revistadelaofil.org/transparencia-equidad-y-acceso-a-los-medicamentos-a-proposito-de-la-pandemia-por-covid-19/

Saiz LC, Erviti J, Leache L, Gutiérrez-Valencia M. Misreporting of a Plasma-Rich-in-Growth-Factors Trial on Knee Osteoarthritis (letter). Arthroscopy 2020;36(3):622-623. https://doi.org/10.1016/j.arthro.2020.01.004

Erviti J, Saiz LC, Leache L, Gutiérrez M, Imízcoz MA. Anticoagulantes de acción directa (ACOD) en nuevas indicaciones...¿de mal en peor? Bit Navarra 2020;28(1):1-23.: http://www.navarra.es/home_es/Temas/Portal+de+la+Salud/Profesionales/Documentacion+y+publicaciones/Publicaciones+tematicas/Medicamento/BIT/Vol+28/BIT+28+N+1.htm

Erviti J, Saiz LC, Leache L, Gutiérrez M, Imízcoz MA. Direct oral anticoagulants (DOACs) for new indications. From bad to worse? DTB Navarre 2020;28(1):1-23. http://www.navarra.es/home_en/Temas/Portal+de+la+Salud/Profesionales/Documentacion+y+publicaciones/Publicaciones+tematicas/Medicamento/BIT/Vol+28/DTB+28+N+1.htm

Garjón J, Saiz LC, Azparren A, Gaminde I, Ariz MJ, Erviti J. First-line combination therapy versus first-line monotherapy for primary hypertension. Cochrane Database of Systematic Reviews 2020, Issue 2. Art. No.: CD010316. DOI: 10.1002/14651858.CD010316.pub3.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010316.pub3/full

Saiz LC, Gil M, Alonso A, Erviti J, Garjón J, Martínez M. Use of methylphenidate and risk for valvular heart disease: A case-control study nested in the BIFAP cohort. Pharmacoepidemiol Drug Saf. 2020;1–8. DOI: 10.1002/pds.4954
https://www.ncbi.nlm.nih.gov/pubmed/32000300

Erviti J, Saiz LC, Alegría L. Medical journals and editorial quality control. ESC Heart Failure (2019). DOI: 10.1002/ehf2.12461
https://onlinelibrary.wiley.com/doi/full/10.1002/ehf2.12461

Erviti J, Saiz LC, Salzwedel DM, Leache L, Pijoan JI, Menéndez Orenga M, Méndez-López I. Blood pressure targets for hypertension in people with chronic renal disease. Cochrane Database of Systematic Reviews 2019, Issue 7. Art. No.: CD008564. DOI: 10.1002/14651858.CD008564.pub2
https://www.cochrane.org/CD008564/HTN_blood-pressure-targets-hypertension-people-chronic-renal-disease

Finizola RM, Infante E, Finizola B, Pardo J, Flores Y, Granero R, Arai KJ, Leache L. Pharmacotherapy for hypertension-induced left ventricular hypertrophy (Protocol). Cochrane Database of Systematic Reviews 2019, Issue 9. Art No.: CD012039. DOI: 0.1002/14651858.CD012039.pub2
https://www.cochrane.org/CD012039/HTN_pharmacotherapy-hypertension-induced-left-ventricular-hypertrophy

Saiz LC, Gorricho J, Garjón J, Celaya MC, Erviti J, Leache L. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease. Cochrane Database of Systematic Reviews 2018, Issue 7. Art. No.: CD010315. DOI: 10.1002/14651858.CD010315.pub3.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010315.pub3/abstract

García-Lorenzo B, Del Pino-Sedeño T, Rocamora R, Erviti J, Serrano-Aguilar P, Trujillo-Martín MM. Stereoelectroencephalography for Refractory Epileptic Patients Considered for Surgery: Systematic Review, Meta-Analysis, and Economic Evaluation. Neurosurgery. 2018 Jul 5. doi:10.1093/neuros/nyy261. [Epub ahead of print]
https://academic.oup.com/neurosurgery/article/84/2/326/5049175

Saiz LC, Erviti J, Garjón J. When authors lie, readers cry and editors sigh. BMJ Evidence-Based Medicine 2018. doi:10.1136/bmjebm-2018-11091
https://ebm.bmj.com/content/23/3/92

Saiz LC. Psicoestimulantes para el TDAH: análisis integral para una medicina basada en la prudencia. Rev Asoc Esp Neuropsiq 2018;38(133):301-30.
http://scielo.isciii.es/pdf/neuropsiq/v38n133/0211-5735-raen-38-133-0301.pdf

Leache L, Saiz LC y Erviti J. Cribado y suplementación de Vitamina D en adultos. Sol y sombras. Bit Navarra 2018;26(4):1-18.
https://www.navarra.es/home_es/Temas/Portal+de+la+Salud/Profesionales/Documentacion+y+publicaciones/Publicaciones+tematicas/Medicamento/BIT/Vol+26/BIT+26+N+4.htm

Leache L, Saiz LC y Erviti J. Vitamin D testing and supplementation in adults. Sun and shadows. DTB Navarre 2018;26(4):1-18. http://www.navarra.es/home_en/Temas/Portal+de+la+Salud/Profesionales/Documentacion+y+publicaciones/Publicaciones+tematicas/Medicamento/BIT/Vol+26/DTB+26+N+4.htm 

Saiz LC. Fumando espero… Estrategias para la deshabituación tabáquica. BIT Navarra 2017;25(4):1-17.
https://www.navarra.es/home_es/Temas/Portal+de+la+Salud/Profesionales/Documentacion+y+publicaciones/Publicaciones+tematicas/Medicamento/BIT/Vol+25/BIT+25+N+4.htm

Saiz LC. WE GOTTA STOP SMOKIN´, STOP STOP...Smoking cessation strategies. DTB Navarre 2017;25(4):1-17.           Hipervínculo: http://www.navarra.es/home_en/Temas/Portal+de+la+Salud/Profesionales/Documentacion+y+publicaciones/Publicaciones+tematicas/Medicamento/BIT/Vol+25/DTB+25+N+4.htm

Boesen K, Saiz LC, Erviti J, Storebø OJ, Gluud C, Gøtzsche PC, Jørgensen KJ. The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder. Evidence-Based Medicine Online First, published on July 13, 2017 as 10.1136/ebmed-2017-110716
https://ebm.bmj.com/content/22/4/143.long

Erviti J, Gorricho J, Saiz LC, Perry T and Wright JM (2017) Rethinking the Appraisal and Approval of Drugs for Fracture Prevention. Front. Pharmacol. 8:265.doi: 10.3389/fphar.2017.00265
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430022/

Gorricho J, Garjón J, Alonso A, Celaya MC, Saiz LC, Erviti J, López A. Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study. Br J Clin Pharmacol. 2017 Mar 11. doi: 10.1111/bcp.13288.
https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.13288

Erviti J, Saiz LC, Garjón J. Mitos y realidades de los nuevos anticoagulantes orales en fibrilación auricular [Myths and reality about new oral anticoagulants in atrial fibrillatin] (Ed). FMC 2017;24:1–4
https://www.fmc.es/es-mitos-realidades-nuevos-anticoagulantes-orales-articulo-S1134207216303577

Formoso G, Font-Pous M, Wolf-Dieter L, Phizackerley D, Bijl D, Erviti J, Pospísilovág B, Montastruc JL. Drug information by public health and regulatory institutions: Results of an 8-country survey in Europe. Health Policy 2017;121:257–264.
https://www.ncbi.nlm.nih.gov/pubmed/28073580

Erviti J, Saiz LC, Garjón J. The reliability of clinical trials. The risky way towards drug deregulation. Med Clin (English Edition) 2016;147(12):554–557.
https://www.elsevier.es/en-revista-medicina-clinica-english-edition--462-articulo-the-reliability-clinical-trials-the-S2387020616307847

Järvinen TL, Michaëlsson K, Jokihaara J, Collins GS, Perry TL, Mintzes B, Musini V, Erviti J, Gorricho J, Wright JM, and Sievänen H. Overdiagnosis of bone fragility in the quest to prevent hip fracture. BMJ 2015;350:h2088
https://www.bmj.com/content/350/bmj.h2088